Clinical trial
A Multicenter, Randomized, Double-blind, Parallel, Controlled Study Assessing the Safety and Efficacy of PEGAVISION Silicone Hydrogel Daily Disposable Soft Contact Lenses (G3)
NCT06995781 is registered in ClinicalTrials.gov with Pegavision Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Parallel, Controlled Study Assessing the Safety and Efficacy of PEGAVISION Silicone Hydrogel Daily Disposable Soft Contact Lenses (G3)
- Lead sponsor
- Pegavision Corporation
- Phase
- Not reported
- Overall status
- Completed
- Start date
- January 21, 2025
- Completion date
- August 14, 2025
- Enrollment
- 69 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
refractive error - myopia simple